Synonym:PaclitaxelCASNumber33069-62-4
EmpiricalFormula(HillNotation)C47H51NO14
MolecularWeight853.91
BeilsteinRegistryNumber1420457
MDLnumberMFCD00869953
PubChemSubstanceID329831125
Properties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsP-R,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Caution
Paclitaxelundergoestransesterificationinmethanolandhydrolyzesinaqueoussolutions.
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheIssuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:1.013mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue
.
Biochem/physiolActions
Paclitaxelisapotentanti-neoplasticandanti-mitotictaxanedrug,whichbindstotheN-terminusofβ-tubulinandandstABIlizesmicrotubulesarrestingthecellcycleattheG2/Mphase.ThemicrotubuledamageinducesapoptosisthroughaJNK-dependentpathwayfollowedbyaJNK-independentpathway,perhapsrelatedtotheactivationofproteinkinaseA(PKA)orofRaf-1kinase,resultinginphosphorylationofBcl-2.AmajormetaboliteviaCYP2CBis6α-hydroxypaclitaxel(6α-OHP).
Safety:
Symbol

GHS08
Hazardstatements
H341-H360
Precautionarystatements
P201-P280-P308+P313
RIDADR
NONHforallmodesoftransport